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REVIEW
PATHOGENESIS OF CHOLESTEROL GALLSTONES
STEVEN M. STRASBERG, PIERRE-ALAIN CLAVIEN and P. ROBERT C.
HARVEY
Department of Surgery and the Samuel Lunenfeld Research Institute, Mount Sinai
Hospital, University of Toronto, Toronto Canada.
Cholesterol gallstone disease is extremely common. Three major stages are recognized for stone
formation, namely bile that becomes supersaturated with cholesterol, cholesterol nucleation leading to
crystal formation and finally retention of the crystals in the gallbladder resulting in stone formation.
Supersaturation is common but nucleation into crystals probably requires protein nucleating factors.
Impaired motility of the gallbladder causes crystal retention and is probably very important in stone
formation.
Cholesterol gallstone disease is one of the most common serious diseases. The
incidence of stone disease is highest in the Americas and Europe with incidence
reaching 30% in women and 15% in men at age 60 in some populations1’2. Mortality
rates vary from 2 to 6 per 100,000 per year depending on the associated incidence
of gallbladder cancer2. For cholesterol gallstones to form, three conditions must be
achieved; the bile must become supersaturated with cholesterol, the cholesterol
must precipitate as solid cholesterol monohydrate crystals and the crystals must
aggregate with other elements of a stone to form the recognizable macroscopic
concretion (Figure 1). In this review we will focus on the pathogenesis of
cholesterol gallstone disease. The first part of the review will deal with the
chemistry of biliary lipids, their secretion into bile and events occurring in bile
which result in the formation of cholesterol crystals. The second part will deal with
the conditions leading to supersaturation, nucleation and stone formation in human
biles.
Relevant chemical species in bile. (Cholesterol, Phospholipid, Bile Salts) Figure 2.
Cholesterol
Cholesterol is the major component of cholesterol gallstones. It is a sterol which is
almost totally insoluble in water, the aqueous solubility being about 10-8mM3.
Cholesterol accounts for about 95% of all sterols in bile and gallstones4.
Cholesterol esters do not exist in bile. The importance of the chemical structure of
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Figure 1 Venn diagram showing the conditions necessary for cholesterol gallstone formation.
cholesterol is that although biliary secretion is a major route for excretion, the
substance is virtually insoluble in water and so carrier systems must be available to
transport the cholesterol in bile. These carriers have finite capacities, which if
exceeded can lead to the precipitation of cholesterol crystals.
Phospholipids
Although there are many different types of hepatic phospholipids, more than 95%
of biliary phospholipid is diacylphosphatidylcholine (lecithin). Lecithin consists of a
glycerol molecule with two fatty acid chains in the sn-1 and sn-2 positions and a
choline group originating from the third glycerol carbon. Lecithins differ in their
fatty acid chain composition, with the least hydrophobic hepatic lecithins selected
for secretion. The commonest biliary lecithins are 16:0-18:2 and 16:0-18:1, with
the pattern of a saturated fatty acid at sn-1 and an unsaturated fatty acid at sn-2
being the common one for most other biliary lecithins also5.
Some differences in lecithin species have been reported between patients with
and without gallstones6’7, but there is incomplete agreement in the results of these
studies and the relevance of the findings is as yet unknown. However, these
observations are potentially quite important since phospholipids contain arachido-
nic acid the precursor substance of prostaglandins, which have important effects on
the gallbladder.
Phospholipids also are very sparingly soluble in water as monomers, but swell in
water to form a bilayer i.e. sheets two molecules thick, in which the fatty acidPATHOGENESIS OF CHOLESTEROL GALLSTONES 81
Bile Salt
Phospholipid
CHEMICAL STRUCTURAL
REPRESENTATION ,-’-’, REPRESENTATION
+ .--,.. //COO Na
(HOLY V ’,.
cholate
(HO v v {OH’
O
CHO-C-R
CH- O-C-R
CH2-O-P-O-CH2-CH2-a,,N(CH3)3
Cholesterol
Figure 2 Chemical species in bile. The three major lipids of interest are shown. Polar groups represented
in black in the structural representation have been circled by an interrupted line in the chemical
representation.
chains project toward the interior of the sheet and the polar choline groups point
outward into the water phase. This is the characteristic positioning of phospholipid
in cell walls and also in biliary mixed micelles and vesicles. A vesicle is a
phospholipid sheet folded to form a hollow sphere of bilayer, enclosing some of the
aqueous medium in the interior. Mixed micelles have a drum like configuration in
which the sheet-like bilayer is the skin of the drum and bile salts are the rim. The
importance of the bilayer in gallstone formation is that it is in the interior of the
bilayer where the fatty acid chains of lecithin provide a highly hydrophobic milieu
that increases cholesterol solubility. Precipitation is possible when these sites
become overloaded, i.e., supersaturated with cholesterol.
Bile Salts
Bile salts are detergent molecules. Their detergent properties are conferred due to
the positioning of a large hydrophobic nucleus of the molecule on one side of the
molecule and polar hydroxyl and carboxyl groups project on other side. Bile salts
are soluble in water but above a very low concentration (about 5mM- the critical82 S.M. STRASBERG ETAL.
micellar concentration or CMC) associate into micelles. The common bile salts in
man are cholate (trihydroxy) and chenodeoxycholate (dihydroxy) which are syn-
thesized in the liver (primary bile salts), and deoxycholate (dihydroxy) and
lithocholate (monohydroxy) produced from the primary bile salts in the intestine by
bacterial dehydroxylation and referred to as secondary bile salts. Bile salts are also
conjugated in the liver to taurine or glycine which, by lowering their pKa, allows
them to remain ionized in the slightly acidic milieu of the upper small intestine,
where otherwise they would be absorbed and not be available for fat digestion. As
noted above bile salts have the capacity to solubilize a section of phospholipid
bilayer into a mixed micelle, making the drum-like mixed micelle referred to
above. Bile salts not only form the rim of the drum but are also inserted into the
skin of the drum among the phospholipids, and so this type of micelle is referred to
as the mixed-disc micelle8. The ability of bile salt to insert into the bilayer is
important since this may be necessary for vesicular aggregation which precedes
nucleation of cholesterol. (see below)
Dynamic and Equilibrium States
The three lipids and water form an interactive system of molecules. In the
cholesterol-lecithin-bile salt-water system cholesterol may be found in at least three
phases or physical forms, i.e., micelles, vesicles, and solid cholesterol monohydrate
crystals. Cholesterol is also present in extremely low concentration as monomers.
The phases which are found are governed by the concentrations of the four
components of the system, and the phase(s) present in a particular model bile may
be accurately predicted by the equilibrium phase diagram for the system provided
the concentrations are known and the system is at equilibrium
9 (Figure 3).
However, mixtures of lipids are not necessarily at equilibrium nor do they
necessarily move to equilibrium rapidly, and may in fact take several days or weeks
to do so. Other components of the system which do not affect the phases present at
equilibrium may nonetheless importantly affect the dynamics of the system,
slowing or accelerating the time to equilibrium. One may by analogy think of the
equilibrium phase diagram as a set of architectural plans; plans depict the static
state reached after construction is complete and one may accurately predict from
those plans where the windows, doors, etc. will be once the building is complete,
i.e. by analogy the static state of equilibrium. However the plans do not permit
determination of state of the construction site during any point in the kinetic or
dynamic state of active construction, nor do they include information on factors
which can accelerate or slow the dynamic process leading to the completion state.
This is a key point in understanding several recent advances in this area, particu-
larly as nucleation of cholesterol crystals is a late kinetic event in biological systems.
Secretion of Biliary Lipids
It has been known for many years that bile salts stimulate the secretion of
cholesterol and phospholipid into bile 1’13. This was initially interpreted to indicate
that bile salt micelles solubilized liver canalicular membrane phospholipid and
cholesterol by detergent action and that the mixed micelles so produced were
secreted into bile. The canalicular membrane was the proposed site of bile salt
action and it was expected that phospholipid composition of canalicular membranePATHOGENESIS OF CHOLESTEROL GALLSTONES 83
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Figure 3 Equilibrium phase diagram for bile salt-phospholipid cholesterol-water at a concentration of
10% solids 90% water. Note that outside the micellar zone two different phases are possible, cholesterol
crystals and vesicles. (From reference 9 by permission)
phospholipids would resemble biliary phospholipids. In fact the composition was
found to be quite different14; biliary phospholipid is almost entirely phosphatidyl
choline, whereas a variety of phospholipid species are present in the canalicular
membrane. Nevertheless, it seemed possible that bile salts might act upon phospha-
tidyl choline (PC) rich domains of the membrane, thus accounting for the particular
composition of bile.
These concepts have had to be completely revised recently because of the
demonstration of unilamellar vesicle in bile by Carey and coworkers in animals- and by Somjen and Gilat in man 16’17. Unilamellar vesicles have now been demon-
strated in the canaliculus itself by Nervi and his colleagues using transmission EM TM.
Cohen et al.
19 employing quasielastic light scattering also provide evidence for
vesicular secretion of biliary lipids. It is highly likely that biliary phospholipid and
cholesterol are co-secreted as vesicles and that the site of origin of the lipid is the
smooth endoplasmic reticulum. Biliary phospholipid appears to originate from a
rapidly turning over pool at that site2, whereas most biliary cholesterol i.e., about
80% is preformed and only 20% is newly synthesized21. Biliary vesicles move to the84 S.M. STRASBERG ET AL.
canalicular pole of the liver cell probably through the Golgi apparatus and fuse with
the canalicular membrane before budding off into the canalicutus2. These pro-
cesses may be inhibited by colchicine, indicating that the cellular microtubular
system is important in vesicular movement from the SER to the canaliculus23. Bile
salts could effect these processes at the SER where they have binding sites24, at the
Golgi or from the canalicular side of the lumen. The latter possibility gains support
from the observation that bile salt concentrations in bile are elevated prior to the
increase in cholesterol or phospholipid concentrations
25 and the observation that
while inorganic anion transport uncouples the effect of bile salts on cholesterol
secretion26, this does not occur in rat strains incapable of anion excretion into the
canaliculus, despite the presence of high concentrations of anion in the liver cell27.
The process of biliary cholesterol secretion must be considered in the context of
total body cholesterol metabolism. Bile salts may be thought of as a signal to
cholesterol traffic to enter the canaliculus. Other signals received by the liver cell
will result in routing of cholesterol into lipoproteins for secretion into the plasma28.
How these signals are processed and how the proportion of cholesterol and
phospholipid in vesicles are determined is unknown. The latter is of extreme
interest in understanding cholesterol gallstone formation since the ratio of choles-
terol to phospholipid in the vesicle determines to a large extent whether or not the
bile will be supersaturated.
Bile salts themselves appear to enter the canaliculus by a carrier mediated
transport process
29 and presumably form simple micelles in the canalicular lumen.
Maturation of Biliary Lipid Carriers in the Biliary Tree
Biliary lipids begin to interact after secretion, the end stage of these interactions
being the equilibrium state. Maturation is the process by which the secreted lipid
carriers are altered in the bile, and maturation, nucleation and crystal growth are
the processes leading from the secreted state to the equilibrium state. As noted
above, the equilibrium state of a particular bile sample is quite predictable at the
moment of secretion from the concentration of the three lipids in the sample,
however the rate at which the kinetic processes proceed is what determines whether
the bile will ever reach equilibrium within the time-scale that it is in the biliary tree.
Thus one supersaturated bile may proceed to equilibrium and solid crystal forma-
tion, while another may remain in a pre-equilibrium state and never form crystals
while in the biliary tree.
As noted in the previous section it seems that all secreted cholesterol and
phospholipid are initially in vesicular form and the C’P ratio of these vesicles is less
than 1.0 even in supersaturated biles. Vesicles with a C:P ratio less than 1.0 are
highly stable, in respect to nucleation of cholesterol3’3; even vesicles with C:P
ratios of 1.5 require several days to nucleate cholesterol crystals3. Maturation
involves two processes, progressive micellation of vesicular phospholipid and
cholesterol and relative enrichment of vesicular cholesterol, i.e., an increase in the
C:P ratio. Micellation is the movement of lipid from vesicle to micelle; studies of
lipid movement between vesicles and between micelles in model systems indicate
several possible mechanisms including transfer of phospholipid and cholesterol
monomers through the aqueous phase and transfer during collision of micelles and
vesicles32’33. There is direct experimental evidence for progressive micellation in
human biles; we have shown that the per cent cholesterol in vesicles in gallbladderPATHOGENESIS OF CHOLESTEROL GALLSTONES 85
bile is less than in hepatic bile34. The concept that human bile vesicles become
relatively enriched in cholesterol during micellation comes from observations on
both human
31 and model biles35. We subjected human bile vesicles to progressively
greater concentrations of bile salt on a column, to simulate the maturation process.
As expected this resulted in progressive micellation, but the process was uneven in
respect to cholesterol and phospholipid, with preference given to micellation of the
phospholipid3. Consequently vesicles were enriched in cholesterol, the C:P ratio
rose and nucleation from these vesicles was accelerated31. The process of matu-
ration is probably accelerated in the gallbladder. There, due to dehydration of bile,
the number of bile salt monomers required to satisfy the CMC is reduced and new
micelles are produced. If the volume of bile is reduced to 20% of initial volume by
water and electrolyte absorption the mass of new simple micelles produced is
substantial. Dehydration may also be important by increasing the probability of
collisions between lipid carriers. Recently we examined a population of persons
with cholesterol crystals but no gallstones. Their gallbladder bile was more
concentrated than bile of a control group without crystals even though the CSI of
the two groups was identical36.
The maturation process in unsaturated and supersaturated bile may be summar-
ized as follows. Unsaturated bile is a condition of micellar excess. At the canalicu-
lus all the cholesterol and phospholipid are in vesicular form and the C:P ratio is
low. As bile moves down the biliary tree there is progressive micellation and
enrichment of residual vesicles in cholesterol. Eventually, since there is micellar
excess, all the vesicular lipid is micellarized. It is at this point that equilibrium is
reached. If the relative composition of the bile is plotted on the equilibrium phase
diagram, it will fall within the micellar zone. The events described above occur in
time and only after all reactions are completed is equilibrium reached; only then
will the phases present in bile correspond to those in the equilibrium phase
diagram. In contrast to the unsaturated state, the supersaturated state is a condition
of micellar insufficiency. In this case after maturation of the lipid carriers is
completed, vesicles with a high C:P ratio remain after micelles become completely
saturated with cholesterol. As this system continues to move toward equilibrium,
cholesterol crystals appear, and at equilibrium either two (crystals and micelles) or
three phases (crystals, micelles and vesicles with a reduced C:P ratio) will be
present. An important corollary is that while maturation is beneficial or at least not
harmful, in undersaturated bile, maturation must be seen as detrimental in
supersaturated bile, since it leads to the conditions necessary for nucleation of
crystals. As reaching the equilibrium state rapidly in supersaturated biles is
undesirable, agents accelerating the lipid transfer processes of maturation must be
pronucleating, whereas agents retarding them are antinucleating. Furthermore,
altering bile salt composition by replacing bile salts with good micelle forming
properties with ursodeoxycholate, a poor micelle forming bile salt, may actually be
beneficial by virtue of slowing this maturation process.
Nucleation of Cholesterol Crystals
Nucleation of cholesterol crystals occurs from biliary vesicles. We have shown that
cholesterol crystals nucleate from human bile vesicles that have been separated
from micelles, but nucleation does not occur from the micelles31. Morphological
studies also support the view that nucleation occurs from the vesicular phase37.86 S.M. STRASBERG ETAL.
Nucleation appears to occur from the small unilamellar vesicles of human bile after
they aggregate
38 (Figure 4A) or after they aggregate and fuse into large multilamel-
lar vesicles38. The latter are much larger than the unilamellar vesicles secreted by
hepatocytes and appear as "Maltese cross" figures on polarizing light microscopy
(Figure 4B); Unilamellar vesicles require EM to be seen. Vesicular lipid is not
uniformly distributed over the surface of the vesicular bilayer; instead cholesterol-
rich and cholesterol-poor zones exist39. As the vesicle becomes enriched in
cholesterol, the proportion of the surface that is cholesterol-rich will increase. It is
not known for sure how aggregation of small unilamellar vesicles (20-100nm) or
their fusion to multilamellar vesicles of much larger size (1000nm) contribute to
nucleation, but it seems likely that the juxtaposition of zones of high concentration
of cholesterol in adjacent vesicles or adjacent lamellae of multilamellar vesicles is
important. For aggregation of vesicles to occur, the repulsion of the polar
phospholipid head groups on the outer leaflet of the vesicle bilayer must be
overcome. This may be how pronucleating substances work. Fusion of unilamellar
vesicles into multilamellar vesicles is a very complex process in which the outer
leaflets of aggregated phospholipid vesicles must retract to expose the fatty acid
tails of the inner leaflets to each other. Exactly how this happens is unknown except
that fusogens appear to insert themselves into the bilayer and distort the bilayer in a
manner promoting these events.
Nucleation is not the end stage of crystal formation. When nucleation occurs
there are very few cholesterol molecules involved and the unit crystal is probably
only 4 molecules. However, little is known about the factors controlling the growth
of unit crystals to crystals observable in the light microscope.
Supersaturation and Cholesterol Gallstone Formation
Supersaturation is the sine qua non of cholesterol gallstone formation, and there is
a linear correlation between the reported CSI of various population groups and the
incidence of cholesterol gallstones in that population (Figure 5)
4o Supersaturation
of bile with cholesterol is extremely common in adults on Western diets. In a large
group of control biles we recently observed the median CSI to be 1.04, i.e.
supersaturated36, indicating that more than one-half of patients having surgery for
non-biliary conditions in our population have supersaturated biles. Many other
studies have also demonstrated that supersaturated bile is extremely common in
our population41-43.
The cause of supersaturation seems to be different depending upon whether the
patient is thin or obese44. Thin patients appear to have a small bile salt pool and a
reduced bile salt secretion rate relative to the secretion rates of cholesterol and
phospholipids, whereas the obese have a normal bile salt pool but increased
secretion of cholesterol44. Cholesterol secretion into bile is directly proportional to
body weight
45 accounting for the effect of obesity on cholesterol saturation in bile.
Obesity promotes supersaturation through another mechanism also, in that choles-
terol secretion rates are markedly increased during periods of rapid weight loss as
body tissues are mobilized46. The thin supersaturated patient is thought to develop
a small bile salt pool by virtue of an inappropriately low response to the stimulus to
bile salt synthesis, i.e. as the pool is lost in the intestine these individuals fail to
respond appropriately by increasing bile salt synthesis levels which would restore
the pool44. Why or how this occurs is unknown. Others have also described aPATHOGENESIS OF CHOLESTEROL GALLSTONES 87
Figure 4 (a) Aggregated unilamellar vesicles seen by electron microscopy. (b) Multilamellar vesicle
measuring about 1000nm shown by polarizing light microscopy. The dark cross-like configuration on the
vesicle is referred to as a Maltese cross and is characteristic.88 S.M. STRASBERG ETAL.
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Figure 5 Estimated prevalence of gallstones in various populations versus reported saturation of
gallbladder bile from the same group. (From reference 40)
reduced bile salt pool in patients with stones47. Bile also tends to become
supersaturated with age. This was first shown in the Chilean population
48 by
Valdevesio et al. (Figure 6). Studies from Sweden have shown that the bile salt
secretion rate, and the bile salt pool diminish with age, while the cholesterol
secretion rate goes up 49. These findings probably account for the increasing
incidence of cholesterol gallstones with age. Estrogens promote cholesterol secre-
tion into bile5, and it seems likely that this is an important factor leading to
supersaturation of bile with cholesterol in females and the preponderance of
51 53 gallstones in females. Diet certainly affects bile composition Vegetarians rarely
form cholesterol gallstones54. A variety of dietary causes have been proposed5-3.
An infrequent cause of supersaturation is intestinal loss of the bile salt pool beyond
the capacity of the hepatic synthesis to compensate as may be seen following ileal
resection or diseases such as regional ileitis55’56.
Bile does not remain supersaturated throughout the day. After meals when the
bile salt pool is cycling, hepatic bile is much less saturated than during the
interdigestive phase, especially the long interdigestive phase which occurs at
night
57-6 (Figure 7). It is also during this period that the greatest degree of
dehydration of bile in the gallbladder may occur.
Nucleation and Cholesterol Gallstone Formation
While supersaturation is very common only a much smaller group of individuals
develop crystals in their bile or go on to form stones. A key observation in this
regard was made by Holan and Holzbach42 who noted that gallbladder bile fromPATHOGENESIS OF CHOLESTEROL GALLSTONES 89
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Figure 6 Lithogenic index in patients above and below 50 years of age in Chile. The lithogenic index is
similar to the cholesterol saturation index in biles with total lipid concentration greater than 2gm/dl as in
this case. (From reference 48)
patients with cholesterol gallstones nucleated cholesterol crystals much more
rapidly than equally supersaturated biles from patients without stones (Figure 8).
They introduced a test called the "nucleation time test" which measured the time
required for the appearance of cholesterol monohydrate crystals in a sample of bile
which had been initially cleared of crystals by ultracentrifugation. This test remains
very useful for examining the effects of proposed pronucleating and antinucleating
factors in bile, but the term "nucleation time" is misleading since it implies
detection of the unit crystal, which is much too small to see. The test detects
crystals many orders of magnitude greater than the unit crystal; therefore it is
measuring crystal growth as well as nucleation time, and a more appropriate term is
"crystal observation time".90 S.M. STRASBERG ET AL.
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Figure 7 Relationship between bile salt secretion and saturation of bile in patients with gallstones (left)
and control patients (right). Low bile salt secretion rates occur at night and between meals when most of
the bile salt pool resides in the gallbladder. (From reference 58)
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Figure 8 Nucleation time versus cholesterol saturation index in gallbladder biles of patients with
cholesterol gallstones (open circles) and in control patients (closed circles). Note that stone patients’
biles nucleate faster despite having similar cholesterol saturation. (From reference 42)PATHOGENESIS OF CHOLESTEROL GALLSTONES 91
Bile contains a variety of substances which influence precipitation of cholesterol
from supersaturated solution, either promoting it (pronucleating factors) or retard-
ing it (antinucleating factors). Several years ago we showed that bile from
cholesterol gallstone patients contains a potent pronucleating factor
61 and much
recent work has been done in this area in an attempt to identify the nature of that
substance. Antinucleating factors have also been found in bile.
Pronucleating Substances
Mucous glycoproteins
Mucous glycoproteins, are a subgroup of glycoproteins with a high carbohydrate
content (over 70% by weight) which contributes substantially to their high molecu-
lar weight (over 106). Mucous glycoproteins are distinguished from serum glycopro-
teins by their low mannose content, and from proteoglycans by lack of uronic acid.
Mucous glycoproteins were implicated in stone formation by the observation that
stones contained a mucopolysaccharide matrix62-64. Subsequently, it was found that
some lithogenic diets caused hypersecretion of mucous glycoprotein in the gallblad-
der prior to stone formation in animals65-68. Aspirin inhibited hypersecretion of
mucous glycoprotein in the prairie dog model and prevented gallstone production
without decreasing cholesterol saturation69. These studies suggested that mucous
glycoprotein might be a pronucleator.
Lee et al. 68 directly examined the effect of mucous glycoprotein on nucleation.
Human gallbladder mucin obtained from gallbladder mucosal scrapings accelerated
the nucleation of cholesterol crystals when added to saturated prairie dog hepatic
bile. Subsequently, it was shown that human gallbladder mucous glycoprotein
accelerates the nucleation time of model bile systems
TM as well as control human
gallbladder biles71.
While there is no doubt that mucous glycoproteins are pronucleators, it is much
less certain that either a quantitative or a qualitative abnormality of these com-
pounds is the nucleation defect responsible for cholesterol gallstone formation. Lee
et al. 72 found a significant increase in the gallbladder mucous glycoprotein concen-
tration in patients with cholesterol gallstones compared to control patients, particu-
larly if sludge was present. On the other hand we found no significant difference in
the gallbladder mucous glycoprotein concentration between the two patient
groups73. Furthermore, in qualitative studies, both the amino acid and carbohyd-
rate content of mucous glycoproteins purified from patients with and without
cholesterol gallstones were shown to be very similar72’73. The only reported
difference in mucous glycoprotein between groups is in sulphate content72’74.
Finally we showed that the mucous glycoprotein purified from normal control bile
was just as effective in accelerating the nucleation time as mucous glycoprotein
obtained from stone former bile7.
Proteins other than mucous glycoproteins
Early investigations in our laboratory showed that patients with cholesterol gall-
stones contained a potent nucleating factor that was not removed by steps which
eliminated mucous glycoprotein6. Purified preparations of biliary proteins were
prepared,removing only the mucous glycoproteins. These proteins were used to
perform an experiment very similar to the one described above for mucous
glycoproteins, i.e. gallbladder proteins obtained from patients with stones and92 S.M. STRASBERG ETAL.
controls without stones were added in identical amounts to control gallbladder
bile75. These results are shown in Figure 9. We found that the proteins from
patients with cholesterol gallstones were better pronucleators than the proteins of
control patients. All protein samples from gallstone patients accelerated nucleation
of control bile, but control patient proteins did so infrequently.
Further purification of the pronucleating protein has been achieved by using
Concanavalin A affinity chromatography of hepatic bile samples76. Nucleation
promoting activity was also reported to be present in patients without cholesterol
gallstones but is less potent. This Con A binding glycoprotein has been shown to
accelerate the nucleation time of model biles in a dose response manner (Figure
10)
77 The number of crystals observed per day was also greater in models
containing the higher concentration of Con A binding glycoprotein. Since mucous
glycoprotein does not bind to Con A these results support the evidence that a non
mucous glycoprotein may have an important role in the formation of cholesterol
gallstones. The glycoprotein must be rich in mannose and/or glucose since it binds
to Con A. Subsequently Groen et al. employing gel filtration chromatography with
a Superose 12 column have found that nucleation promoting activity eluted in two
peaks with molecular weights of 150 +/-30 kDa and < 5 kDa respectively. The < 5
kDa protein is believed to be a degraded product of the 150 kDa protein78. The
identity of the 150 kDa glycoprotein remains to be determined. Our own most
recent studies suggest that the pronucleating protein is of larger molecular weight
and that it is probably an immunoglobulin79.
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Figure 9 Reduction in nucleation time of control slowly nucleating bile produced by the addition of
purified gallbladder bile protein from stone patients or controls. The mass of protein added was the
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Figure 10 Effect of Con A glycoprotein on nucleation time. (From reference 77)
Other pronucleating substances
Calcium and bilirubin have been proposed to be pronucleating substances. A
common observation is that the centre of all cholesterol stones is pigmented and it
has been shown that there is calcium as well as other inorganic substances in the
centre of stones8’8. Calcium bilirubinate does not appear to accelerate
nucleation2, and the removal of calcium by chelation did not retard nucleation82.
However, addition of calcium did appear to accelerate nucleation in a model bile94 S.M. STRASBERG ETAL.
system35. Recently it has been shown that the addition of calcium to human
gallbladder bile does not accelerate the nucleation time but the number of crystals
formed was increased83. Calcium does promote aggregation and fusion of certain
types of phospholipid vesicles, although not phosphatidyl choline vesicles84.
Antinucleating substances
Apolipoproteins
The nucleation time of model bile is more rapid than that of equally supersaturated
bile obtained from normal persons85. This observation suggested that normal bile
contained stabilizing antinucleating factors. Holzbach et al. determined that these
nucleation inhibiting factors were bile proteins; detergent delipidated biliary
proteins isolated from the bile of stone-free individuals prolonged the nucleation
time when added to model bile85. Preincubation of these bile proteins with pronase
destroyed the nucleation inhibiting effect. This was the first study implicating
biliary proteins as cholesterol crystal nucleation inhibitors. A preliminary attempt to
isolate and identify the anti-nucleating protein by gel filtration showed that the
major antinucleating activity eluted in the included volume of the column. Whether
proteins which co-eluted with the biliary lipids were associated with the lipids or
eluted with lipids due to similar molecular size, was not determined. The most
likely explanation however, as suggested by Holzbach et al. is that these proteins
interact with bile lipids possibly forming complexes similar to the lipoproteins of
serum85.
Support for the role of apolipoproteins came from the work of Sewell et al.
86 and
Ohisalo et al.
87 who demonstrated their presence in human gallbladder bile.
Subsequently, purified serum apolipoproteins, namely apoprotein A-l, A-2, and
C-3, were added to model biles to study their effect on nucleation time88.
Apoprotein A-1 and A-2 inhibited the rate of formation of cholesterol crystals in
supersaturated model bile systems. Apoprotein C-3 had no effect. Furthermore,
Apoprotein A-1 and A-2 were identified in the included gel filtration fraction
shown previously to contain the cholesterol nucleation inhibiting factor88. These
results strongly suggest that Apoproteins A-1 and A-2 are proteins that inhibit
cholesterol crystal nucleation in human supersaturated gallbladder bile. One might
expect then that the concentration of these proteins would be higher in patients
without gallstones. However, this was not found to be so. The concentrations of
Apoprotein A-1 and A-2 is similar in patients with and without gallstones86.
Other possible nucleation inhibiting proteins
Groen et al. recently reported nucleation inhibiting activity in human bile in the
unbound protein fraction from a Concanavalin A Sepharose lectin column76. The
nucleation inhibiting fraction was unstable; inhibiting activity was lost after 24 hr at
37C. This nucleating inhibiting protein may be Apolipoprotein A-l, which does
not contain carbohydrates89, and would not bind to Con A. The activity of this
factor is transient at 37C likely because it is denatured by endogenous proteolytic
enzymes in gallbladder bile76.
Holzbach’s group has used several lectins in order to isolate nucleating and anti-
nucleating proteins from normal gallbladder bile9. The protein fraction isolated by
Helix pomatia, a lectin specific for N-acetyl-D-galactosamine
91 inhibited both
nucleation and crystal growth. This protein fraction was reported to have greaterPATHOGENESIS OF CHOLESTEROL GALLSTONES 95
potency than Apolipoprotein A-1. The identity of this factor remains to be
determined.
Mode of action ofpronucleating and antinucleating substances
There are at least four mechanisms for altering the rate of appearance of crystals.
First the rate of maturation of biliary vesicles could be altered, accelerating or
delaying the production of vesicles with a high cholesterol:phospholipid ratio.
There is some evidence that the Con A pronucleating protein acts in this way92.
Nucleation rates from such mature vesicles could also be altered by substances
promoting aggregation or fusion of vesicles. Certain proteins as well as other
substances have been implicated as aggregating agents
93-96 or fusogens97-1a, and the
biliary proteins which are being described as pronucleating or antinucleating could
act in this way. Finally the agents could act by accelerating or slowing crystal
growth.
From Crystal to Stone Stasis and Glue
Crystalbilia does not necessarily lead to stones any more than supersaturation leads
to crystalbilia. Although there are many aspects of supersaturation and crystal
formation yet to be understood, nowhere is knowledge more lacking than in the
processes which lead from crystals to stones. There are two guiding facts. Stones
are complex structures consisting of a matrix and inorganic salts as well as
cholesterol and these non-cholesterol materials may have the role of binding the
stone together. Secondly, crystals are excreted from the gallbladder, so for stones
to form there must be a period of crystal retention, i.e. stasis.
There are multiple lines of evidence that abnormalities in motility are important
in stone formation. There is an increased incidence of stones in situations where
stasis occurs, such as pregnancy12, treatment with female sex hormones12’3,
during fasting14’15, and in patients on total parenteral nutrition (TPN)4’6. Stasis
may also contribute to stone formation after vagotomy7’18.
TPN associated stone formation may be due to stasis secondary to decreased
gallbladder stimulation. Patients receiving some oral supplementation have a much
lower incidence of stone formation than those who receive no oral intake14’19.
Although such stones may be cholesterol in type, they are usually pigment
stonesTM.
The increased risk of gallstones in multiparous females
1 may be due in part to
gallbladder stasis. Gallbladder emptying is impaired in the third trimester of
pregnancy when progesterone levels are highest12’11-12. It has been found that
pregnant women and women taking contraceptive steroids have increased gallblad-
der volumesTM. In female guinea pigs, gallbladder contractile response to CCK is
related to the number of progesterone receptors in the gallbladder walljt, with
maximum contractility occurring after oophorectomy when progesterone levels are
lowest. Conversely, progesterone pretreatment decreases the response to CCK or
acetylcholine14’15. In pregnant guinea pigs the response to CCK is reduced whereas
the response to extracellular potassium chloride is unaffected16, this suggests that
the effect of sex hormones is at the receptor level and that the gallbladder muscle is
itself unimpaired.
There is now strong evidence that the composition of the bile may affect
gallbladder motility, and particularly that high cholesterol concentrations reduce
motility by a direct non-receptor mediated effect on the muscle of the gallbladder.96 S.M. STRASBERG ETAL.
Behar has recently shown that human gallbladders exposed to a high cholesterol
environment have decreased contractility when tested in oitro 117, and it has been
known for some time that impaired contractility precedes the development of
stones in animals fed a high cholesterol diet 116. This impairment is present even
when agents which stimulate muscle are used, indicating that the problem is at the
level of the muscle cell. The means by which contractility is impaired by high levels
of cholesterol is unknown. Cholesterol is incorporated into cell membranes, and
can affect membrane fluidity8’19 and perhaps the operation of ion channels, but
whether this is the mechanism whereby contraction is impaired is presently
unknown.
Prostaglandins have been implicated as the mediators of dysmotility in some
studies2. Prostaglandins are stimulators of biliary smooth muscle12-123, and the
early increase in cystic duct resistance induced by a high cholesterol lithogenic diet
correlated with PGE concentration and PGFalpha synthesis in the galibladderTM.
Some authors have shown a biphasic response to prostaglandins with initial
increased motility followed by a decrease in motility121125’126, and it has been
suggested that impairment of emptying may result from superimposed changes in
both gallbladder contractility and cystic duct resistance.
Direct measurements of gallbladder emptying in humans with gallstones have
produced somewhat conflicting results. Shaffer reported a subgroup of patients
with decreased motility127, but this study also implies that many patients develop
stones without an impairment in motility. Such studies are difficult to evaluate
because the stimulus to contraction is exogenous. The effect of stasis is to give time
for such kinetic events as maturation, nucleation and crystal growth to occur, as
well as to allow for retention of crystals in the gallbladder. Stasis also gives extra
time for concentration of bile to occur. As noted above, we have found crystal
formation to be associated with high total lipid and protein concentrations in the
gallbladder36, and this could be brought about by stasis. Stasis appears to result in
the formation of sludge. Sludge is a complex precipitate consisting mainly of
calcium bilirubinate and mucous glycoprotein. However, sludge may also contain
cholesterol crystals128, and some patients who developed sludge have gone on to
form cholesterol gallstones128. Sludge is an ultrasonic finding and may not always be
present when crystals are in bile. We have found that persons without ultrasonic
evidence of sludge may have many cholesterol crystals in bile36; such bile is
frequently very high in total lipid concentration suggesting prolonged residence in
gallbladder, i.e. stasis36. It should also be remembered that there are zones or
layers in the gallbladder containing bile of different concentration, i.e. bile can
separate into elements of different density in the gallbladder129. Certain of these
zones may not exchange in the same way as others, forming areas of stasis in a
gallbladder that is otherwise functioning normally in terms of contraction.
Cholesterol crystals left in a test tube will not form a stone. At most, loose
aggregates of several hundred crystals form. At present, little can be said about
how the disparate elements of a stone come together or why some persons form a
single stone and others form multiple stones. The scaffolding matrix of mucous
glycoprotein would appear to be essential. Mucous glycoprotein is in solution in the
bulk phase of bile, i.e. in the centre of the gallbladder, but on the wall it is in gel
form. It is possible that the earliest assembly of a stone takes place in this area. As
noted above, the centre of most cholesterol gallstones contains calcium bilirubi-
nate, and it is possible that this substance acts as an agglomerating agent forPATHOGENESIS OF CHOLESTEROL GALLSTONES 97
cholesterol crystals at an early stage of stone formation. Many more studies are
required to understand these early events in stone formation.
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